about
Spontaneous fungal peritonitis: Epidemiology, current evidence and future prospectiveRisk of spontaneous fungal peritonitis (SFP) in hospitalized cirrhotic patients with ascites: a systematic review of observational studies and meta-analysis.Is anticoagulation with novel oral anticoagulants an effective treatment for tuberculosis patients not achieving a therapeutic range with vitamin k antagonists? A Systematic Review.Nosocomial spontaneous bacterial peritonitis antibiotic treatment in the era of multi-drug resistance pathogens: A systematic review.The Possible Role of Anti-Methicillin-Resistant Staphylococcus Aureus Antimicrobial Agents in Spontaneous Bacterial Peritonitis.Spontaneous peritonitis in critically ill cirrhotic patients: a diagnostic algorithm for clinicians and future perspectivesTreatment of spontaneous bacterial peritonitis: beyond the current international guidelines.Foot infections in diabetes (DFIs) in the out-patient setting: an Italian multicentre observational survey.In vitro activity of tigecycline: MICs, MBCs, time-kill curves and post-antibiotic effect.Current concepts and future strategies in the antimicrobial therapy of emerging Gram-positive spontaneous bacterial peritonitis.The beneficial use of ultramicronized palmitoylethanolamide as add-on therapy to Tapentadol in the treatment of low back pain: a pilot study comparing prospective and retrospective observational arms.Are third-generation cephalosporins still the empirical antibiotic treatment of community-acquired spontaneous bacterial peritonitis? A systematic review and meta-analysis.The diagnostic conundrum of bacterial infections in cirrhotic patients.Nosocomial spontaneous bacterial peritonitis: discussing a specific infection treatment algorithm.Liver fungal infections: an overview of the etiology and epidemiology in patients affected or not affected by oncohematologic malignancies.A proposal algorithm for patients presenting to the Emergency Department with renal colic.Outcomes assessment of hepatitis C virus-positive psoriatic patients treated using pegylated interferon in combination with ribavirin compared to new Direct-Acting Antiviral agents.Contrast-enhanced ultrasound as imaging technique for patients with acute flank pain into the ED.Spontaneous bacterial peritonitis due to multidrug resistant bacteria: are the current guidelines outdated?Liver Illness and Psoriatic Patients.Letter: the emergence of multi-drug resistant spontaneous bacterial peritonitis: a new challenge for the hepatologist?Use of antifungals in critically ill cirrhotic patients with spontaneous peritonitis.Saliva as a Future Field in Psoriasis Research.Reactivation of overt and occult hepatitis B infection in various immunosuppressive settingsClinical applications of palmitoylethanolamide in pain management: protocol for a scoping reviewOutpatient Parenteral Antibiotic Therapy for Bone and Joint Infections: An Italian Multicenter StudyNonalcoholic fatty liver disease prevalence in an Italian cohort of patients with hidradenitis suppurativa: A multi-center retrospective analysisCurrent controversies and future perspectives on treatment of intensive care unit delirium in adults.Community-acquired pneumonia: is it time to shorten the antibiotic treatment?Preemptive therapy of spontaneous fungal peritonitisAntimicrobial Lock Therapy in Clinical Practice: A Scoping Review ProtocolEffectiveness of dexmedetomidine as adjunctive therapy, compared to the standard of care in the treatment of alcohol withdrawal syndrome: a systematic review protocolChoosing the appropriate pharmacotherapy for multidrug-resistant Gram positive infectionsNew antibiotics for the treatment of serious infections in intensive care unit patientsNeutrophilic Dermatoses and Their Implication in Pathophysiology of Asthma and Other Respiratory Comorbidities: A Narrative ReviewSpontaneous bacterial peritonitis caused by Gram-negative bacteria: an update of epidemiology and antimicrobial treatmentsNew antimicrobial options for the management of complicated intra-abdominal infectionsShould endotoxin be a research priority in Gram-negative sepsis and septic shock?Use of colistin in adult patients: A cross-sectional studyChanges in the relative prevalence of candidaemia due to non-albicans Candida species in adult in-patients: A systematic review, meta-analysis and meta-regression
P50
Q28069942-A88D282E-E807-46FA-8C66-D04E9B219418Q38670830-82D50534-50F0-40E5-81EC-26F4881E373CQ38694244-F92C4EA5-B86A-4458-BF4C-CFEF817C9646Q39455604-E9234145-AA5A-4F15-A5B8-3832768C546BQ40837656-EE11774D-2973-42D6-AC3E-A1CDC99B69B7Q42649815-ECC89373-99F8-4C5B-95EA-0B3482F241E3Q44210692-E6EB3DBB-C0BF-4A27-AB61-48E52C5DA111Q44973997-41B7A108-2793-4B9D-9313-8E4ED5D9CDE5Q46231679-2DF6E6B8-4108-43B2-B5BB-7F1C80249C86Q47099854-86FB5E8E-9B43-485A-B597-E98D81CD180BQ47127221-52597801-EF02-470E-B603-AC20B96B9787Q47750067-82A882A7-73E8-4323-BA0A-2F3E25852E0AQ48157102-ABFCAE79-FE42-4C28-86A7-BCE8780D2551Q48258925-CDB10B99-19AD-4FCA-9246-7FD053A8BC3BQ50019528-1094E960-B24D-438D-ADA9-14D0ADC3C479Q50568906-D219E77C-A9D1-4097-BB55-5E0B0815B147Q52661693-C03B49E7-F363-4B82-97E5-F4F62B6F4857Q52987235-EC5B797F-DB89-4615-B6EA-3F5DB3851A5BQ53788744-068A7466-03B8-49E2-A59F-A75F7C643C50Q54254957-FE75E991-F98D-4A31-87BF-FC0C87CBA003Q54586580-70A7837C-5C1B-4FB6-97D4-3350761680B5Q54680177-1FFA973D-2375-4D8F-BD96-FB0D702A567AQ55057884-E638D8B4-4E03-4544-BEEE-0FC480FA6A12Q60232557-788A1EFF-645A-4625-9ADC-885002EE4A3BQ60918045-E9F542EE-BB03-471E-BE2E-BD64D326A53BQ61631267-0AC5FF67-3F82-4ACC-85C2-540186AE2BB0Q64084156-8DFC79C3-F872-43AC-8574-05FFBE5DF0C8Q64992119-EE76DD91-C39C-4F94-9B80-D6A47B049B93Q80013003-23B017DF-C51D-4483-9A1C-01EBFF0FF66CQ87055558-452E8B55-859B-430C-98CB-432AD21CCFC3Q89720055-81B7CA63-D6A4-4903-A5D3-163F1ABCE0D6Q90872813-884C41DE-62EC-4327-935A-F41012E512C0Q91043885-20A6F1BD-48CA-4CA5-BE2C-4C336C2E26FEQ91552949-2E501947-DEEE-4578-9BFF-638FFC6636F5Q91693198-13D151E5-25D6-44E7-A3B4-327B61A56BCFQ92155279-EA31A4F0-6787-408E-BB87-1FB0C3AE717AQ92567627-A9AA34C0-33E2-41B2-90AE-EC16AC509307Q92717472-07DBFD16-9B3F-4D09-B76F-6E1268D3E58EQ92810811-3DE5ADFF-E9C0-4C18-AAF6-11CD3F9CBE69Q93044893-70983C47-BC76-4F39-A5C7-9ADFE65AF765
P50
description
investigador
@es
researcher
@en
name
M Fiore
@en
M Fiore
@nl
type
label
M Fiore
@en
M Fiore
@nl
prefLabel
M Fiore
@en
M Fiore
@nl
P108
P108
P31
P496
0000-0001-7263-0229